Piedmont Silke, Swart Enno, Kenmogne Rosie, Braun-Dullaeus Rüdiger C, Robra Bernt-Peter
Institut für Sozialmedizin und Gesundheitsökonomie, Med. Fakultät, Universität Magdeburg, Germany.
Institut für Sozialmedizin und Gesundheitsökonomie, Med. Fakultät, Universität Magdeburg, Germany.
Z Evid Fortbild Qual Gesundhwes. 2017 Nov;127-128:62-71. doi: 10.1016/j.zefq.2017.06.004. Epub 2017 Jul 13.
Diagnostic left heart catheterization (LHC) is recommended if the therapeutic consequences of a bypass operation or percutaneous coronary intervention (PCI) are being considered. The present study examines regional differences in healthcare provision and therapeutic consequences of LHC, differentiated by counties and hospitals of the German federal state of Saxony-Anhalt. In addition, it looks at which patient-related factors influence the proportion of follow-up interventions. The relation between the rates of LHC, interventions and hospital discharge due to myocardial infarction is examined.
The data of 9,791 individuals having statutory health insurance coverage by the AOK Saxony-Anhalt with 10,906 anonymized inpatient cases of LHCs in 2011 were followed until 12/31/2012, and it was examined whether they subsequently received a coronary bypass or PCI. The data was used to compare both the counties of Saxony-Anhalt (according to residence, adjusted for age and sex) and their hospitals. Regression analysis was run to identify determinants of receiving a LHC without consequences.
Overall, 54.2 % of the patients with LHC had no invasive follow-up intervention. Regression analysis showed an approximately linear relationship for the counties: the number of LHCs provided correlates with the number of LHCs requiring no PCI or bypass within a period of at least 12 months. Regional LHC rates are not correlated with hospitalizations due to acute myocardial infarction. No bypass or PCI in the follow-up period was reported for 37 to 85 % of the cases, depending on the hospital providing the LHC. Women and younger patients have a higher risk to undergo LHC without therapeutic impact.
The analysis indicates that there are specific regions in Saxony-Anhalt and diagnoses where the indications for LHC should be more conservative. However, more detailed analyses are needed to verify the identified potentials for improving healthcare provision.
如果考虑进行搭桥手术或经皮冠状动脉介入治疗(PCI)的治疗后果,推荐进行诊断性左心导管检查(LHC)。本研究考察了德国萨克森 - 安哈尔特州各县及医院在医疗服务提供和LHC治疗后果方面的地区差异。此外,研究了哪些患者相关因素会影响后续干预的比例。还考察了LHC率、干预措施与因心肌梗死住院出院之间的关系。
对2011年德国萨克森 - 安哈尔特州AOK法定医疗保险覆盖的9791名个体以及10906例匿名的LHC住院病例的数据进行追踪,直至2012年12月31日,考察他们随后是否接受了冠状动脉搭桥手术或PCI。这些数据用于比较萨克森 - 安哈尔特州的各县(根据居住地,按年龄和性别进行调整)及其医院。进行回归分析以确定接受无后果LHC的决定因素。
总体而言,接受LHC的患者中有54.2%没有进行侵入性后续干预。回归分析显示各县之间存在近似线性关系:在至少12个月的时间段内,提供的LHC数量与不需要PCI或搭桥的LHC数量相关。地区LHC率与急性心肌梗死导致的住院情况无关。根据提供LHC的医院不同,随访期间37%至85%的病例未报告进行搭桥手术或PCI。女性和年轻患者接受无治疗效果LHC的风险更高。
分析表明,在萨克森 - 安哈尔特州存在特定地区和诊断情况,LHC的适应症应更保守。然而,需要更详细的分析来验证所确定的改善医疗服务提供的潜力。